Intl. Biotechnology Trust PLC
9 November 2000
Letter to: Company Announcements Office
SUBSTANTIAL SHARE INTEREST NOTIFICATION
We are writing to advise you that the Company was notified on 9 November 2000,
that Charlamont Trading Limited, is interested in 3,285,000 ordinary shares of
25p each, representing 3.73% of the 88,002,177 ordinary shares in issue,
following a purchase of 1,000,000 shares on 6 November 2000.
Soros Fund Management LLC acts as principal investment advisor to Quantum
Endowment Fund N.V., the operating subsidiary of which is Quantum Partners LDC.
Charlamont Trading Limited is a 100% trading subsidiary of Quantum Partners and
in consequence Quantum Partners LDC and Quantum Endowment Fund N.V. have also
acquired an interest in the shares. The registered holder of the shares is
Morgan Stanley International Nominees Limited as Custodian for Charlamont
Trading Limited.
Letter from: Schroder Investment Management Ltd.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.